MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities,available for sale$468,961K Cash and cashequivalents$61,148K Prepaid expenses andother assets$13,276K Total current assets$543,385K Property and equipment,net$7,831K Operating leaseright-of-use asset$1,387K Total assets$552,603K Total liabilities andstockholders' equity$552,603K Total stockholders'equity$522,257K Total liabilities$30,346K Accumulated deficit-$546,371K Additional paid-in capital$1,067,941K Total currentliabilities$27,370K Operating leaseliability, net of current...$2,976K Accumulated othercomprehensive income$677K Common stock, .0001 parvalue per share...$10K Accrued compensation$12,430K Accrued other expenses$7,920K Accounts payable$6,006K Operating leaseliability, current portion$1,014K
Balance Sheet
source: myfinsight.com

Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics, Inc. (EWTX)